With the results from one study the polymorphism was thought to be related to treatment response so that long-allele patients respond better to antidepressants [REF].
One study could find a treatment response effect for repetitive transcranial magnetic stimulation to drug-resistant depression with long/long homozygotes benefitting more than short-allele carriers.